It is strange GSK doesn't mention the primary endp
Post# of 148187
(Total Views: 512)
Posted On: 03/26/2021 11:18:02 AM
It is strange GSK doesn't mention the primary endpoint (Proportion of participants who have progression of COVID-19 through Day 29). The results are based on 583 patients but with no mention of the number of patient hospitalized or dead in each arm, what's the confidence interval?
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼